Document is current
Any future updates will be listed below
-
Authors
Thijs, Roland D. https://orcid.org/0000-0003-1435-8970
Raj, Satish R. https://orcid.org/0000-0002-5890-3785
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 22 November 2023
First Online: 23 December 2023
Declarations
:
: RDT reports personal fees from UCB, Theravarance, Novartis, Eisai, LivAssured, Xenon, Angelini, Zogenix, and Arvelle and grants from Medtronic and NewLife Wearables. SRR is a Consultant for Theravance Biopharma, Amneal Pharma, Servier Affaires Medicales, Regeneron, Antag Therapeutics, and Argenx BV. The authors confirm that they have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Free to read: This content has been made available to all.
